Skip to main content
. 2017 Aug 10;10(6):443–454. doi: 10.1111/cts.12490

Figure 2.

Figure 2

Bridging information, including exposure–response relationships, from the original patient population studied in clinical trials to specific populations that will receive the drug in real‐world clinical practice.